Sanofi And Japan’s National Cancer Research Center Sign Alliance For Cancer Drug Development
This article was originally published in PharmAsia News
Executive Summary
The Japanese National Cancer Research Center and Sanofi signed a basic agreement with the aim of speeding up clinical development of new cancer drug candidates.